发明名称 |
BINDING DRUGS WITH NANOCRYSTALLINE CELLULOSE (NCC) |
摘要 |
This invention describes nanocrystalline cellulose (NCC) for use as a drug delivery excipient. NCC binds significant quantities of water soluble, ionizable drugs, e.g., tetratcycline and doxorubicin, which are released rapidly over a one day period. A surfactant such as cetyl trimethylammonium bromide (CTAB) can bind to the surface of NCC and increase the zeta potential in a concentration-dependent manner from -55 to 0 mV. NCC with CTAB modified surfaces can bind significant quantities of the hydrophobic drugs such as anticancer drugs docetaxel, paclitaxel and etoposide. These drugs were released in a controlled manner over a 2-day period. The NCC-CTAB nanocomplexes were found to bind to KU-7 cells and evidence of cellular uptake was observed. |
申请公布号 |
CA2816216(C) |
申请公布日期 |
2013.11.26 |
申请号 |
CA20112816216 |
申请日期 |
2011.11.22 |
申请人 |
FPINNOVATIONS |
发明人 |
BURT, HELEN MARY;JACKSON, JOHN KEVIN;HAMAD, WADOOD YASSER |
分类号 |
A61K47/38;A61K9/20;A61K47/34 |
主分类号 |
A61K47/38 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|